Loading company…
Mirvie uses an RNA platform and blood tests to predict pregnancy complications.
Founded in 2019 by Maneesh Jain and Stephen Quake, California-based Mirvie develops a blood test and RNA platform to predict pregnancy complications. It analyzes RNA from the baby, placenta, and mother using machine learning. In July 2025, the company raised USD 23.7 million in Series B funding led by BlackRock, with participation from Decheng Capital, Foresite Capital, General Catalyst Partners, GV, Khosla Ventures, Mayfield Fund, and other investors. It plans to expand its flagship product.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in